Hopital Necker-Universite Paris Descartes

Paris 75015

0 studies enrolling now · 3 studies all time

What they study most

ADPKD, Alport Syndrome, Autosomal Dominant Polycystic Kidney, Chronic Kidney Diseases

Studies at this site

• A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL — Completed
• An Extended Access Program for Bardoxolone Methyl in Patients With CKD (EAGLE) — Stopped early
• A Trial of Bardoxolone Methyl in Patients With ADPKD - FALCON — Stopped early